Elevation Point Wealth Partners LLC Makes New $921,000 Investment in The Cooper Companies, Inc. $COO

Elevation Point Wealth Partners LLC purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 12,839 shares of the medical device company’s stock, valued at approximately $921,000.

Several other institutional investors have also recently made changes to their positions in the business. New York Life Investment Management LLC grew its position in Cooper Companies by 0.6% during the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after buying an additional 158 shares during the period. Root Financial Partners LLC increased its stake in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares in the last quarter. Essential Partners LLC increased its stake in shares of Cooper Companies by 23.4% in the 1st quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock worth $62,000 after purchasing an additional 166 shares in the last quarter. Allworth Financial LP lifted its position in Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after purchasing an additional 167 shares in the last quarter. Finally, SJS Investment Consulting Inc. lifted its position in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Get Cooper Companies alerts:

Cooper Companies Trading Down 0.6%

COO stock opened at $75.80 on Tuesday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The business has a 50 day simple moving average of $72.09 and a two-hundred day simple moving average of $71.07. The company has a market capitalization of $14.78 billion, a price-to-earnings ratio of 64.24, a PEG ratio of 1.99 and a beta of 0.83.

Cooper Companies (NASDAQ:COO – Get Free Report) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter last year, the business posted $0.96 earnings per share. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on COO. Mizuho set a $85.00 price objective on Cooper Companies and gave the stock an “outperform” rating in a research note on Thursday, June 4th. JPMorgan Chase & Co. decreased their target price on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research note on Friday, June 5th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the company an “overweight” rating in a research report on Monday, June 1st. Finally, Weiss Ratings cut shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $81.64.

Get Our Latest Research Report on Cooper Companies

Cooper Companies Profile

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Read More

• Five stocks we like better than Cooper Companies
• Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
• Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
• Snowflake Could Be Headed for New Highs Despite Insider Selling
• MongoDB Is Surging—And the Next Catalyst Is Almost Here

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.